Holen Sie sich die Stockscreener-App
183.99
1.28%
2.33
Handel nachbörslich:
183.99
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$181.66
Offen:
$180.97
24-Stunden-Volumen:
449.42K
Relative Volume:
0.56
Marktkapitalisierung:
$11.74B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
17.66
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
+1.83%
1M Leistung:
-19.30%
6M Leistung:
+18.86%
1J Leistung:
+35.73%
1-Tages-Spanne:
$179.95
$184.13
1-Wochen-Bereich:
$175.47
$184.13
52-Wochen-Spanne:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
183.99 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
405.00 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.05 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.66 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.79 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. stock gains support from solid Q2 2026 earnings - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - AD HOC NEWS
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - AD HOC NEWS
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
DaVita $15M Data Breach Settlement 2026: What It Pays - shattered.io
NewsDaVita to pay $15 million to settle data breach lawsuit affecting millions of dialysis patients - teiss
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Eastern Progress
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack - tradingview.com
DaVita (DVA) Has Investors Asking A Fresh Question - Yahoo Finance
DaVita Inc. stock gains support from higher earnings and steady guidance - AD HOC NEWS
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita agrees to pay $15M to settle claims from data breach - medtechdive.com
DaVita Inc. stock holds near 179 dollars after strong 2026 earnings momentum - AD HOC NEWS
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report? - Yahoo Finance
Do Options Traders Know Something About DaVita Stock We Don't? - tradingview.com
DaVita Community Care Report 2025: Leading With Integrity and Accountability - CSRwire
DaVita Inc. stock gains after data breach settlement and partnership expansion - AD HOC NEWS
DaVita (NYSE:DVA): Is the Humana Deal Unlocking More Value? - Kalkine Media
DaVita stock trades around $180 as Q2 2026 growth and kidney-care partnership shape expectations - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita stock holds $180.72 as earnings beat and guidance stand out - AD HOC NEWS
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity - DirectorsTalk Interviews
DaVita stock holds above $180 as Q2 earnings and analyst targets shape the outlook - AD HOC NEWS
Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative? - simplywall.st
DaVita stock steadies as new Humana partnership follows strong Q2 results - AD HOC NEWS
Enterprise value to revenue forward of DaVita Inc. – NYSE:DVA - tradingview.com
Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease - marketscreener.com
DaVita Reaches Kidney Care Agreement With Humana - marketscreener.com
DaVita Defeats Nurse Overtime Collective Bid - Law360
DaVita Inc. (DVA) Stock Analysis: Potential 25.66% Upside For Healthcare Investors - DirectorsTalk Interviews
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
Patients Share Their Experiences With Expanded HD - DaVita Newsroom
DaVita (DVA) Financial Results: EPS Exceeds Its Estimate on the Day; Market Response: The Stock Loses 0.36%Strong Earnings Momentum - Vinanet
DaVita stock slips after Q2 revenue beats forecasts - Ad-hoc-news.de
DaVita (NYSE: DVA) reports new insider stock trade - Stock Titan
DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award - Stock Titan
DaVita (NYSE: DVA) insider logs new stock trade in SEC filing - Stock Titan
DaVita (NYSE: DVA) director now holds 5,970 shares after award - Stock Titan
Forever Committed to Excellence in Care: DaVita Community Care Report 2025 - CSRwire
News by ACCESS Newswire on TradingView, 2026-08-18 - TradingView
DaVita Inc. (DVA) Stock Analysis: A Strong ROE And 21% Potential Upside - DirectorsTalk Interviews
Enterprise value to revenue forward of DaVita Inc. – BX:TRL - TradingView
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):